38513667|t|P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.
38513667|a|Neuronal loss is the central issue in Alzheimer's disease (AD), yet no treatment developed so far can halt AD-associated neurodegeneration. Here, we developed a monoclonal antibody (mAb2A7) against 217 site-phosphorylated human tau (p-tau217) and observed that p-tau217 levels positively correlated with brain atrophy and cognitive impairment in AD patients. Intranasal administration efficiently delivered mAb2A7 into male PS19 tauopathic mouse brain with target engagement and reduced tau pathology/aggregation with little effect on total soluble tau. Further, mAb2A7 treatment blocked apoptosis-associated neuronal loss and brain atrophy, reversed cognitive deficits, and improved motor function in male tauopathic mice. Proteomic analysis revealed that mAb2A7 treatment reversed alterations mainly in proteins associated with synaptic functions observed in murine tauopathy and AD brain. An antibody (13G4) targeting total tau also attenuated tau-associated pathology and neurodegeneration but impaired the motor function of male tauopathic mice. These results implicate p-tau217 as a potential therapeutic target for AD-associated neurodegeneration.
38513667	25	42	neurodegeneration	Disease	MESH:D019636
38513667	46	65	Alzheimer's disease	Disease	MESH:D000544
38513667	121	127	murine	Species	10090
38513667	128	137	tauopathy	Disease	MESH:D024801
38513667	139	152	Neuronal loss	Disease	MESH:D009410
38513667	177	196	Alzheimer's disease	Disease	MESH:D000544
38513667	198	200	AD	Disease	MESH:D000544
38513667	246	248	AD	Disease	MESH:D000544
38513667	260	277	neurodegeneration	Disease	MESH:D019636
38513667	321	327	mAb2A7	Chemical	-
38513667	361	366	human	Species	9606
38513667	367	370	tau	Gene	4137
38513667	443	456	brain atrophy	Disease	MESH:C566985
38513667	461	481	cognitive impairment	Disease	MESH:D003072
38513667	485	487	AD	Disease	MESH:D000544
38513667	488	496	patients	Species	9606
38513667	546	552	mAb2A7	Chemical	-
38513667	568	578	tauopathic	Disease	
38513667	579	584	mouse	Species	10090
38513667	626	629	tau	Gene	4137
38513667	688	691	tau	Gene	4137
38513667	702	708	mAb2A7	Chemical	-
38513667	748	761	neuronal loss	Disease	MESH:D009410
38513667	766	779	brain atrophy	Disease	MESH:C566985
38513667	790	808	cognitive deficits	Disease	MESH:D003072
38513667	846	856	tauopathic	Disease	
38513667	857	861	mice	Species	10090
38513667	896	902	mAb2A7	Chemical	-
38513667	1000	1006	murine	Species	10090
38513667	1007	1016	tauopathy	Disease	MESH:D024801
38513667	1021	1023	AD	Disease	MESH:D000544
38513667	1044	1048	13G4	Chemical	-
38513667	1066	1069	tau	Gene	4137
38513667	1086	1089	tau	Gene	4137
38513667	1115	1132	neurodegeneration	Disease	MESH:D019636
38513667	1173	1183	tauopathic	Disease	
38513667	1184	1188	mice	Species	10090
38513667	1261	1263	AD	Disease	MESH:D000544
38513667	1275	1292	neurodegeneration	Disease	MESH:D019636
38513667	Association	MESH:D019636	4137

